dc.creator | Safe, Stephen H. | |
dc.creator | Chintharlapalli, Sudhakar | |
dc.creator | Mcalees, Alan | |
dc.creator | Mccrindle, Robert | |
dc.date.accessioned | 2019-06-17T17:07:18Z | |
dc.date.available | 2019-06-17T17:07:18Z | |
dc.date.issued | 2013-03-05 | |
dc.identifier.uri | https://hdl.handle.net/1969.1/177024 | |
dc.description.abstract | The present invention relates to novel derivatives of glycyrrhetinic acid, compositions comprising said derivatives and their use in the treatment of conditions or diseases that benefit from an upregulation of PPAR&ggr and/or a downregulation of the expression or activity of one or more specificity (Sp) proteins, such as cancer, diabetes and Huntington's disease. | en |
dc.language | eng | |
dc.publisher | United States. Patent and Trademark Office | |
dc.rights | Public Domain (No copyright - United States) | en |
dc.rights.uri | http://rightsstatements.org/vocab/NoC-US/1.0/ | |
dc.title | Glycyrrhetinic acid derivatives | en |
dc.type | Utility patent | en |
dc.format.digitalOrigin | reformatted digital | en |
dc.description.country | US | |
dc.contributor.assignee | Wellington Laboratories Inc. | |
dc.contributor.assignee | The Texas A&M University System | |
dc.identifier.patentapplicationnumber | 12/308798 | |
dc.subject.uspcprimary | 514/510 | |
dc.subject.uspcother | 560/116 | |
dc.date.filed | 2007-06-27 | |
dc.publisher.digital | Texas A&M University. Libraries | |
dc.subject.cpcprimary | A61P 1/00 | |
dc.subject.cpcprimary | A61P 25/14 | |
dc.subject.cpcprimary | A61P 1/18 | |
dc.subject.cpcprimary | A61K 31/122 | |
dc.subject.cpcprimary | A61P 25/00 | |
dc.subject.cpcprimary | A61P 3/10 | |
dc.subject.cpcprimary | A61P 13/08 | |
dc.subject.cpcprimary | A61P 25/28 | |
dc.subject.cpcprimary | A61P 35/00 | |
dc.subject.cpcprimary | C07J 63/008 | |
dc.subject.cpcprimary | A61P 43/00 | |